Clinical Trials Browser

Phase 1 × Vulvar Neoplasms × Docetaxel × Clear all

NCT00287885 2017-11-29

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms